Anthrogen
Latest round
- Seed
Last raised
- Sep 2024
Total raised
- $4M
Investors
- 9
About Anthrogen
, trading under the name Anthrogen, operates as a biotechnology research company focusing on carbon-negative polymers, utilizing genetically engineered bacteria for environmental sustainability and industrial applications. Ankit Singhal (CEO), Connor Lee (CTO), and Vignesh Karthik (COO) are the co-founders of the company. The company focused on scalable, carbon-negative polymer manufacturing, leveraging advanced genetic engineering to create solutions for a sustainable future. The firm’s unified platform integrates a next-generation protein foundry and enzymatic cascade technology, engineered to produce environmentally friendly feedstocks. Central to Anthrogen’s innovation is the development of the photosynthesizing organism, engineered using CRISPR technology. This technology enables the production of carbon-based materials, including recalcitrant polymers for carbon capture, alkane mixes for jet fuel, and alternatively branched starches for industrial applications.
Who invested in Anthrogen
9 investors across 1 round
See all investors in Anthrogen
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Sep 23, 2024
Amount
$4M
Investors
Questions about Anthrogen
Who invested in Anthrogen?
Anthrogen has 9 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Anthrogen raised?
Anthrogen has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Anthrogen last raise money?
Anthrogen's most recent round on record is a Seed, in Sep 2024.
What does Anthrogen do?
, trading under the name Anthrogen, operates as a biotechnology research company focusing on carbon-negative polymers, utilizing genetically engineered bacteria for environmental sustainability and industrial applications.
Where is Anthrogen headquartered?
Anthrogen is headquartered in San Francisco, US.
Which VCs invest in companies like Anthrogen?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Anthrogen's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Anthrogen? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.